Market Overview

JP Morgan Maintains Overweight on Aegerion Pharmaceuticals, Inc., Raises PT to $30.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for AEGR

DateFirmActionFromTo
Feb 2016Bank of AmericaDowngradesNeutralUnderperform
Dec 2015GuggenheimUpgradesSellBuy
Nov 2015Bank of AmericaUpgradesUnderperformNeutral

View More Analyst Ratings for AEGR
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (AEGR)